Page last updated: 2024-09-04

moxifloxacin and cangrelor

moxifloxacin has been researched along with cangrelor in 2 studies

Compound Research Comparison

Studies (moxifloxacin)	Trials (moxifloxacin)	Recent Studies (post-2010) (moxifloxacin)	Studies (cangrelor)	Trials (cangrelor)	Recent Studies (post-2010) (cangrelor)
3,157	552	1,690	418	54	286

Protein Interaction Comparison

Protein	Taxonomy	moxifloxacin (IC50)	cangrelor (IC50)
Ornithine decarboxylase	Rattus norvegicus (Norway rat)		0.0004
P2Y purinoceptor 12	Homo sapiens (human)		0.0043

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Bellibas, SE; Green, CL; Krucoff, MW; Lambe, L; Prats, J; Whellan, DJ; Wijngaard, P	1

Trials

1 trial(s) available for moxifloxacin and cangrelor

Article	Year
Electrocardiographic safety of cangrelor, a new intravenous antiplatelet agent: a randomized, double-blind, placebo- and moxifloxacin-controlled thorough QT study. Journal of cardiovascular pharmacology, 2013, Volume: 62, Issue:5 Topics: Adenosine Monophosphate; Adolescent; Adult; Aza Compounds; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Follow-Up Studies; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Quinolines; Time Factors; Young Adult	2013

Article

Year

Electrocardiographic safety of cangrelor, a new intravenous antiplatelet agent: a randomized, double-blind, placebo- and moxifloxacin-controlled thorough QT study.

Journal of cardiovascular pharmacology, 2013, Volume: 62, Issue:5

Topics: Adenosine Monophosphate; Adolescent; Adult; Aza Compounds; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Follow-Up Studies; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Quinolines; Time Factors; Young Adult

2013

Other Studies

1 other study(ies) available for moxifloxacin and cangrelor

Article	Year
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012

Article

Year

Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.

Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012